This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa
The drug HYCAMTIN contains one active pharmaceutical ingredient (API):
|
1
Topotecan
UNII 956S425ZCY - TOPOTECAN HYDROCHLORIDE
|
|
Topotecan involves the inhibition of topoisomerase-I, an enzyme intimately involved in DNA replication. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| HYCAMTIN Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
| HYCAMTIN Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01CE01 | Topotecan | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CE Topoisomerase 1 (TOP1) inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 4617B, 7260D |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 526517080090317 |
| Country: EE | Ravimiamet | Identifier(s): 1044627, 1071076, 1213748, 1213759, 1364598, 1364600 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 96027001, 96027006, 96027007 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 126374, 126385 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61126871, 63093822, 63901015 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 142260, 142263, 48028, 73158 |
| Country: HK | Department of Health Drug Office | Identifier(s): 41723, 57841, 57842 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 88560, 88585 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 3401, 6352 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4240408D1037 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003757, 1003758, 1004910, 1004911, 1006524, 1028878, 1089213 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 46442, 87181, 87203 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100094363, 100137977, 100192410, 100192427 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64499001 |
| Country: SG | Health Sciences Authority | Identifier(s): 09415P, 13707P, 13708P |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699504790900, 8699504790917 |
| Country: US | FDA, National Drug Code | Identifier(s): 0078-0672, 0078-0673, 0078-0674 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 31/26/0300, 42/26/0740 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
